CHICO, Calif. — Olivia Owlett chose to do her primary care residency in this Northern California college town largely because it faces many of the same health care challenges she grew up with. Owlett is one of four residents in the inaugural class of a three-year family medicine residency program run by the local nonprofit…
What is Double descent.Repeal of Noneconomic Damage Caps and Medical Malpractice Insurance Premiums.Reform of FDA use of external experts?Deep learning for solving economic models.Did RFK Jr. make former CDC Chief roll back vaccine policies without evidence?
Susan Monarez, the former director of the Centers for Disease Control and Prevention, testified before the Senate Health, Education, Labor, and Pensions Committee on Sept. 17 in her first public remarks since she was fired. Some Republicans on the committee accused her of lying and said she hadn’t been on board with the administration’s agenda….
Consumers can see their out-of-pocket costs skyrocket, both in premiums and in out-of-pocket costs, if Congress continues to do nothing, healthcare advocate says
Lōvu Health’s Series A round was led by SJF Ventures and included participation from Rogue Women’s Fund, Symphonic Capital, Emmeline Ventures and Majella Ventures. The post Lōvu Health Rakes In $8M for Maternal Health Platform appeared first on MedCity News.
Duke University Health System is deploying a mix of homegrown and purchased AI tools to ease clinicians’ administrative burden and improve patient care. Chief Nurse Executive Terry McDonnell highlighted that while AI can’t replace nurses’ judgment, it can help free up their time for what matters most. The post Inside Duke’s Approach to Building and…
President Trump has been pursuing policies intended to entice drugmakers to bring manufacturing and jobs to the U.S. GSK’s announcement makes it the latest big pharma company to unveil a multi-billion dollar plan for new U.S. facilities. The post GSK Plans to Spend $30B on U.S. Manufacturing and R&D Infrastructure Over the Next 5 Years…
At HL7’s annual Plenary and Working Group Meeting, stakeholders demonstrated medical-dental interoperability efforts involving two use cases
As an industry, we need to ask hard questions. Are delegated vendors delivering on the promise of better, faster, more transparent decisions? Or are they simply moving the pain to another part of the system? The post The Delegation Dilemma: Why It’s Time for Health Plans to Rethink Vendor-Managed Utilization Management appeared first on MedCity…
This analysis examines PEPFAR spending and HIV viral suppression rates in 22 countries from 2018–2023 to help identify which investments most effectively drive HIV outcomes and inform future directions.